Get the Stockscreener App
0.663
4.59%
-0.0319
After Hours:
.66
-0.003
-0.45%
Profusa Inc stock is traded at $0.663, with a volume of 333.58K.
It is down -4.59% in the last 24 hours and down -27.70% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.
See More
Previous Close:
$0.6949
Open:
$0.7
24h Volume:
333.58K
Relative Volume:
0.08
Market Cap:
$901.26K
Revenue:
$75,000
Net Income/Loss:
$-39.09M
P/E Ratio:
-0.00234
EPS:
-283.7191
Net Cash Flow:
$-11.45M
1W Performance:
-45.66%
1M Performance:
-27.70%
6M Performance:
-97.14%
1Y Performance:
+0.00%
1-Day Range:
$0.63
$0.71
1-Week Range:
$0.63
$1.30
52-Week Range:
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.663 | 944.63K | 75,000 | -39.09M | -11.45M | -283.72 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profusa Inc Stock (PFSA) Latest News
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why did PFSA stock surge 80% pre-market today? - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Crude Oil Gains 3%; Alignment Healthcare Shares Jump - Sahm
Dow Falls 200 Points; US Durable Goods Orders Decline In February - Sahm
Gold Edges Higher; ISM Services PMI Falls In March - Sahm
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
What's Going On With Profusa Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Profusa expands into precision diagnostics market - Medical Buyer
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - bitget.com
Profusa to acquire multi-omics platform, partners with Mayo Clinic By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Monday's session: top gainers and losers - ChartMill
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Curious about the most active stocks on Monday? - ChartMill
Profusa shares surge after $30M PanOmics acquisition LOI signals pivot into molecular diagnostics - Quiver Quantitative
Profusa (PFSA) Stock Soars 173% on $30M PanOmics Diagnostics Acquisition - Blockonomi
US Stocks Mixed; Nasdaq Gains Over 100 Points - Benzinga
Profusa (PFSA) Stock Rockets 173% After $30M Oncology Platform Deal - CoinCentral
Profusa’s Strategic Meeting Sparks Investment Talks - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Is Profusa Stock Soaring Monday?Profusa (NASDAQ:PFSA) - Benzinga
Profusa Inc. Signs $30 Million Non-Binding LOI to Acquire PanOmics Assets from Bio Insights LLC - Minichart
Profusa expands into multi-billion dollar precision diagnostics market with $30m letter of intent for a PanOmics platform - marketscreener.com
Profusa Expands Convertible Note Capacity to $12.22 Million, Issues $555,555 12% Note - TradingView — Track All Markets
Profusa to acquire multi-omics platform, partners with Mayo Clinic - investing.com
Profusa (Nasdaq: PFSA) signs $30M PanOmics diagnostics LOI - Stock Titan
$Profusa (PFSA.US)$ tap in and out for a quick scalp - Moomoo
Profusa Expands into Multi-Billion Dollar Precision - GlobeNewswire
Trending Stocks Today | Profusa Soars 126.91% Pre-Market - Moomoo
Profusa, Inc. entered into a non-binding letter of intent to acquire Certain assets of Bio Insights LLC from Bio Insights LLC for $30 million. - marketscreener.com
PFSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
NVACW SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Delays Annual Report Amid Wider Losses - TipRanks
Profusa (NVACW) delays 2025 Form 10-K; $31.9M loss after merger - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PFSA Should I Buy - Intellectia AI
Profusa Incenters amendment to promissory note with Northview Sponsor I LLC on March 20, 2026SEC filing - marketscreener.com
Profusa Extends Promissory Note Maturity, Enhancing Liquidity - TipRanks
Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Profusa (PFSA) Stock Forecast and Price Target 2026 - MarketBeat
NVACW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):